China Shineway Pharmaceutical Group Limited
CSWYYOTCHealthcare● Active
$19.25
+$0.00(+0.00%)
Market Cap$36353625
P/E Ratio—
52W High$22.54
52W Low$19.25
China Shineway Pharmaceutical Group Limited（CSWYY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CSWYY · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.05B | $3.78B | $4.52B | $4.02B | $3.18B |
| Cost of Revenue | $0.85B | $0.95B | $1.12B | $1.01B | $0.81B |
| Gross Profit | $2.20B | $2.83B | $3.39B | $2.94B | $2.41B |
| Gross Margin %(computed) | 72.28% | 74.95% | 75.15% | 73.09% | 75.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.10B | $0.11B | $0.12B | $0.11B |
| G&A Expenses | $0.00B | $0.29B | $0.33B | $0.28B | $0.26B |
| Total Operating Expenses | $1.54B | $1.99B | $2.42B | $2.22B | $1.85B |
| Operating Income | $0.66B | $0.84B | $0.98B | $0.73B | $0.53B |
| Operating Margin %(computed) | 21.75% | 22.30% | 21.60% | 18.06% | 16.58% |
| Interest Income | $0.21B | $0.18B | $0.10B | $0.09B | $0.10B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $1.23B | $1.15B | $1.24B | $0.93B | $0.71B |
| Income Tax Expense | $0.31B | $0.31B | $0.27B | $0.19B | $0.16B |
| Net Income | $0.92B | $0.84B | $0.97B | $0.72B | $0.56B |
| Net Margin %(computed) | 30.30% | 22.24% | 21.47% | 17.98% | 17.50% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $489.40 | $444.00 | $512.20 | $384.00 | $296.00 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | $0.73B | $1.22B | $1.42B | $1.10B | $0.90B |
| EBITDA Margin %(computed) | 24.01% | 32.31% | 31.44% | 27.45% | 28.40% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CNY · B
深入了解China Shineway Pharmaceutical Group Limited
关于China Shineway Pharmaceutical Group Limited（CSWYY）损益表
China Shineway Pharmaceutical Group Limited（CSWYY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CSWYY实现营收$3.05B，毛利润$2.20B（毛利率72.28%），净利润$0.92B（净利率30.30%）。
常见问题
CSWYY · 4 问China Shineway Pharmaceutical Group Limited（CSWYY）2025财年营收为$3.05B，同比down19.3%。
CSWYY revenueCSWYY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09